Results
|
1.
|
|
|
2.
|
|
|
3.
|
Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]. [electronic resource] by
- Mischoulon, D
- Hylek, L
- Yeung, A S
- Clain, A J
- Baer, L
- Cusin, C
- Ionescu, D F
- Alpert, J E
- Soskin, D P
- Fava, M
Publication details: Journal of affective disorders 02 2018
In:
Journal of affective disorders vol. 227
Availability: No items available.
|
|
4.
|
|
|
5.
|
Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram. [electronic resource] by
- Svenningsson, P
- Berg, L
- Matthews, D
- Ionescu, D F
- Richards, E M
- Niciu, M J
- Malinger, A
- Toups, M
- Manji, H
- Trivedi, M H
- Zarate, C A
- Greengard, P
Producer: 20150605
In:
Molecular psychiatry vol. 19
Availability: No items available.
|
|
6.
|
cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor. [electronic resource] by
- Fujita, M
- Richards, E M
- Niciu, M J
- Ionescu, D F
- Zoghbi, S S
- Hong, J
- Telu, S
- Hines, C S
- Pike, V W
- Zarate, C A
- Innis, R B
Producer: 20170629
In:
Molecular psychiatry vol. 22
Availability: No items available.
|